Annexon, Inc. (NASDAQ: ANNX) is a Healthcare company (Biotechnology) with a market capitalization of $569M. The Maz Rating grades it against the other companies in its sector.
Annexon, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.47, Annexon, Inc. trades at 5.0x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -106.8%, return on invested capital of -95.3% and a free cash flow yield of -33.2%. On the balance sheet: a debt-to-equity ratio of 0.51 and a current ratio of 5.79. Over the past 52 weeks the share price ranged from $2.99 to $7.18, with a beta of 1.44.
Annexon, Inc. does not currently pay a dividend.
11 Wall Street analyst ratings cover the stock: 10 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.